Pro-inflammatory and pro-apoptotic properties of Human Defensin 5

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 557-562

  Lu, Wuyuan ^a   de Leeuw, Erik ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial peptide; Apoptosis; Human Defensin 5; Interleukin 8; Intestinal epithelium

Indexed keywords

BCL2 RELATED PROTEIN A1; DEFENSIN; DEFENSIN 5; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MATRILYSIN; STROMELYSIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; IMMUNITY; INFLAMMATION; INTESTINE EPITHELIUM CELL; PANETH CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANTIMICROBIAL PEPTIDE; APOPTOSIS; HUMAN DEFENSIN 5; INTERLEUKIN 8; INTESTINAL EPITHELIUM;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CACO-2 CELLS; CASPASE 3; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; DEFENSINS; HUMANS; INFLAMMATION; INTERLEUKIN-8; INTESTINAL MUCOSA; NF-KAPPA B; PANETH CELLS; TRANSCRIPTION, GENETIC;

EID: 84879886110     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.015     Document Type: Article

References (44)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
2. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
3. Schutte B.C., Mitros J.P., Bartlett J.A., Walters J.D., Jia H.P., Welsh M.J., Casavant T.L., McCray P.B. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc. Natl. Acad. Sci. USA 2002, 99:2129-2133.
4. Patil A., Hughes A.L., Zhang G. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics 2004, 20:1-11.
5. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991, 251:1481-1485.
6. Szyk A., Wu Z., Tucker K., Yang D., Lu W., Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 2006, 15:2749-2760.
7. Pazgiera M., Hoover D.M., Yang D., Lu W., Lubkowski J. Human beta-defensins. Cell. Mol. Life Sci. 2006, 63:1294-1313.
8. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525-528.
9. Grigat J., Soruri A., Forssmann U., Riggert J., Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J. Immunol. 2007, 179:3958-3965.
10. Soruri A., Grigat J., Forssmann U., Riggert J., Zwirner J. Beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur. J. Immunol. 2007, 37:2474-2486.
11. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002, 23:291-296.
12. Bowdish D.M., Davidson D.J., Hancock R.E. Immunomodulatory properties of defensins and cathelicidins. Curr. Top. Microbiol. Immunol. 2006, 306:27-66.
13. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6:551-557.
14. Porter E.M., Bevins C.L., Ghosh D., Ganz T. The multifaceted Paneth cell. Cell. Mol. Life Sci. 2002, 59:156-170.
15. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima H., Fellermann K., Ganz T., Stange E.F., Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 2005, 102:18129-18134.
16. Wehkamp J., Wang G., Kubler I., Nuding S., Gregorieff A., Schnabel A., Kays R.J., Fellermann K., Burk O., Schwab M., Clevers H., Bevins C.L., Stange E.F. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J. Immunol. 2007, 179:3109-3118.
17. Wehkamp J., Schmid M., Fellermann K., Stange E.F. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukoc. Biol. 2005, 77:460-465.
18. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., Yadav S.P., Crabb J.W., Ganz T., Bevins C.L. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 2002, 3:583-590.
19. Ericksen B., Wu Z., Lu W., Lehrer R.I. Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob. Agents Chemother. 2005, 49:269-275.
20. Wu Z., Ericksen B., Tucker K., Lubkowski J., Lu W. Synthesis and characterization of human alpha-defensins 4-6. J. Pept. Res. 2004, 64:118-125.
21. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
22. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
23. Fellermann K., Wehkamp J., Herrlinger K.R., Stange E.F. Crohn's disease: a defensin deficiency syndrome?. Eur. J. Gastroenterol. Hepatol. 2003, 15:627-634.
24. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003, 422:522-526.
25. Salzman N.H., Hung K., Haribhai D., Chu H., Karlsson-Sjoberg J., Amir E., Teggatz P., Barman M., Hayward M., Eastwood D., Stoel M., Zhou Y., Sodergren E., Weinstock G.M., Bevins C.L., Williams C.B., Bos N.A. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 2010, 11:76-83.
26. Elphick D., Liddell S., Mahida Y.R. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am. J. Pathol. 2008, 172:702-713.
27. de Leeuw E., Burks S.R., Li X., Kao J.P., Lu W. Structure-dependent functional properties of human defensin 5. FEBS Lett. 2007, 581:515-520.
28. Fishbein T., Novitskiy G., Mishra L., Matsumoto C., Kaufman S., Goyal S., Shetty K., Johnson L., Lu A., Wang A., Hu F., Kallakury B., Lough D., Zasloff M. Nod 2 expressing bone marrow derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2007.
29. Simms L.A., Doecke J.D., Walsh M.D., Huang N., Fowler E.V., Radford-Smith G.L. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008.
30. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M.F., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
31. Steinbrecher K.A., Harmel-Laws E., Sitcheran R., Baldwin A.S. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J. Immunol. 2008, 180:2588-2599.
32. Abreu M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010, 10:131-144.
33. Gong J., Xu J., Zhu W., Gao X., Li N., Li J. Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin. Immunol. 2010, 136:245-256.
34. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., Ouellette A.J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 2000, 1:113-118.
35. Yang D., Chen Q., Chertov O., Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 2000, 68:9-14.
36. Territo M.C., Ganz T., Selsted M.E., Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 1989, 84:2017-2020.
37. Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., Holtz D.O., Jenkins A., Na H., Zhang L., Wagner D.S., Katsaros D., Caroll R., Coukos G. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 2004, 10:950-958.
38. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., Kwak L.W. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298:1025-1029.
39. Candille S.I., Kaelin C.B., Cattanach B.M., Yu B., Thompson D.A., Nix M.A., Kerns J.A., Schmutz S.M., Millhauser G.L., Barsh G.S. A -defensin mutation causes black coat color in domestic dogs. Science 2007, 318:1418-1423.
40. Cole A.M., Ganz T., Liese A.M., Burdick M.D., Liu L., Strieter R.M. Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 2001, 167:623-627.
41. Durr M., Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 2002, 70:6515-6517.
42. Khine A.A., Del Sorbo L., Vaschetto R., Voglis S., Tullis E., Slutsky A.S., Downey G.P., Zhang H. Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 2006, 107:2936-2942.
43. Soehnlein O., Kai-Larsen Y., Frithiof R., Sorensen O.E., Kenne E., Scharffetter-Kochanek K., Eriksson E.E., Herwald H., Agerberth B., Lindbom L. Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J. Clin. Invest. 2008, 118:3491-3502.
44. de Leeuw E., Rajabi M., Zou G., Pazgier M., Lu W. Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett. 2009, 583:2507-2512.